2 MG Bortezomib Injection IP

Product Description

The Topmeds Company is an outstanding supplier, trader and exporter, located in Mumbai, Maharashtra, India, engaged in offering an exclusive range of the 2 MG Bortezomib Injection IP. It is an antineoplastic agent, mainly used to treat people with multiple myeloma and with mantle cell lymphoma. We make sure to provide the quality-tested range of the medicines, which are processed hygienically under the guidance of team of expertise. You can avail the offer of the 2 MG Bortezomib Injection IP at market leading rates.

Bortezomib is used to treat people with multiple myeloma (a type of cancer of the bone marrow). Bortezomib is also used to treat people with mantle cell lymphoma (a fast-growing cancer that begins in the cells of the immune system). Bortezomib is in a class of medications called antineoplastic agents.